Thank you Letter to, Outgoing Chief Executive Officer, Mr. Stefano Gnes, for his Excellent Service to EASL International Liver Foundation

June 5, 2019 4:21 pm Published by Leave your thoughts1 Comment% Comments

July 31st 2019 marks the end of EASL International Liver Foundation directorship of Mr. Stefano Gnes. He has done an outstanding job shaping EASL International Liver Foundation for what it is today. EASL International Liver Foundation thanks Mr. Gnes for an extra ordinary work and leadership skills in the message from the Chairman of the Board.

 

 

 

Tags:

Categorised in:

This post was written by Stefano Gnes

PRESS RELEASE: EASL International Liver Foundation Launch the first Center of Excellence in Viral Hepatitis Elimination in Georgia

April 14, 2019 8:24 am Published by Leave your thoughts1 Comment% Comments


EASL International Liver Foundation Launch the first Center of Excellence in Viral Hepatitis Elimination in Georgia Vienna, Austria, 13 April 2019 — The EASL International Liver Foundation (EILF), today announced the launch of the first ever Centre of Excellence in Viral Hepatitis Elimination to showcase leading efforts to eliminate viral hepatitis and to fuel other countries to kick-start or expand and enhance their programs. The initiative was developed in collaboration with the US Centers for Disease Prevention and Control.

Read Complete Press Release here: EILF Press Release_COE

Tags:

Categorised in:

This post was written by admin_eilf

HEPATITIS C ELIMINATION IN KUWAIT NOW RELEASED

April 3, 2019 8:53 pm Published by Leave your thoughts1 Comment% Comments

Globally, there are more than 70 million people living with chronic hepatitis C virus (HCV), which causes significant morbidity and mortality as it can lead to liver damage, liver cancer and liver failure. Within the World Health Organization (WHO) Eastern Mediterranean region alone, there is an estimated 15 million people living with HCV.1
In 2015, the United Nations General Assembly adopted the 2030 Agenda for Sustainable Development, which called for significant action to combat viral hepatitis − raising its profile as a public health issue. In 2016, the World Health Assembly adopted the first global health sector strategy on viral hepatitis, setting targets for the elimination of viral hepatitis as a public health threat by 2030. The strategy was endorsed by 194 countries, including Kuwait.
With approved screening and diagnostic tests as well as the advent of direct acting antivirals that can cure ≥95% of patients with HCV with easy to administer and highly tolerable treatment regimens, we have the biomedical tools to eliminate HCV. Despite this, only 12 of the 194 countries that endorsed the WHO global health sector strategy are on track to reach the WHO elimination targets.2
The EASL International Liver Foundation works with countries to support their progress towards viral hepatitis elimination. As such, the foundation convened key Kuwaiti experts and stakeholders in a half-day expert panel meeting with the main aim of identifying the successes, gaps, and barriers to HCV elimination in Kuwait and to determine unified recommendations to facilitate and expedite elimination in the country.
In support of the WHO global health sector strategy on viral hepatitis for 2016-2021 and the Eastern Mediterranean regional action plan for the implementation of global health sector strategy on viral hepatitis 2017-2021 and consistent with the United Nations’ Sustainable Development Goals and the WHO universal health coverage framework, this report presents expert recommendations to empower Kuwait to fast-track HCV elimination.

Tags:

Categorised in:

This post was written by admin_eilf

WORKSHOP HIGHLIGHTS REPORT: VIRAL HEPATITIS ELIMINATION IN PWID

December 11, 2018 5:46 pm Published by Leave your thoughts1 Comment% Comments

 

EASL International Liver Foundation joined forces with San Patrignano, Europe’s largest drug rehabilitation community, to hold a one-day Viral Hepatitis Elimination in PWID: A Roadmap to Elimination in Italy workshop on 10 October 2018 in Rimini, Italy.
Italy is making significant strides with its viral hepatitis strategy and is one of the 12 countries on track to eliminate viral hepatitis as a public health threat by 2030. This workshop sought to accelerate progress towards national elimination by providing the platform to identify and champion the conditions necessary to fast-track viral hepatitis elimination among people at highest risk of acquiring and transmitting the virus; people who inject drugs (PWID).
The workshop brought together leading experts in viral hepatitis, the drug treatment community and key stakeholders such as government officials, industry representatives, civil society organisations and scientific societies. The programme, presented by international and local experts, provided the latest updates on viral hepatitis treatment in PWID while providing participants with the unique opportunity to network and exchange experiences and ideas for viral hepatitis elimination among PWID in Italy.
Bringing the stakeholders together, this workshop aimed to not only kick-start the call to action for viral hepatitis elimination among PWID in Italy but to also set the foundations for the generation of a roadmap for elimination.
The workshop took place in the San Patrignano rehabilitation community, Rimini, Italy and was accredited by the Italian Ministry of Health Italian Ministry of Health for 6 CME Credits (ID. N. 150-234009).

 

Tags:

Categorised in:

This post was written by admin_eilf

“Viral Hepatitis Elimination in PWID: A Roadmap to Elimination in Italy”: Registrations now open

September 17, 2018 5:44 pm Published by Leave your thoughts1 Comment% Comments

This one-day workshop entitled “Viral Hepatitis Elimination in PWID: A Roadmap to Elimination in Italy” is co-organised by EASL International Liver Foundation (EILF) and the San Patrignano Community and will bring together leading experts in viral hepatitis, the drug treatment community in Italy and key stakeholders such as government officials, industry representatives, patient organisations and scientific societies.

The programme, presented by international experts, aims to provide the latest updates on viral hepatitis treatment in PWID while providing participants with the unique opportunity to network and exchange experiences and ideas for viral hepatitis elimination among people who inject drugs (PWID) in Italy.

Bringing all the stakeholders together, this workshop aims to not only kick-start the call to action for viral hepatitis elimination in PWID in Italy but to also generate a multi-stakeholder plan of action to turn this vision into reality.

We look forward to welcoming you to San Patrignano, Italy on 10 October 2018!

REGISTER NOW: 

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: EILF Session at the Emirates Gastroenterology and Hepatology conference, 22-24 November 2018

June 14, 2018 3:08 pm Published by Leave your thoughts1 Comment% Comments

EILF will be heading back to Dubai in November 2018 to attend the Emirates Gastroenterology and Hepatology 2018 Conference in Dubai, where Prof. Massimo Colombo, Prof. Kosh Agarwal, Prof. Maria Buti and Prof. Guilio Marchesini  will hold an EILF Guidance on Liver Disease session.

 

 

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: The first EILF School of Excellence, 28 September 2018

June 14, 2018 3:07 pm Published by Leave your thoughts1 Comment% Comments

EILF have recently embarked on a collaboration with the Emirates Gastroenterology and Hepatology Society and together, we will hold the first School of Excellence on 28 September 2018 in Dubai. This full day interactive school will be led by EILF and local experts providing a mix of state of the art lectures, debates and clinical case presentations.

 

 

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: GOLD Summit II, 29 September 2018

June 14, 2018 3:06 pm Published by Leave your thoughts1 Comment% Comments

EILF are heading back to the Kingdom of Saudi Arabia for the second Guidance on Liver Disease (GOLD) Summit, which we are co-hosting in collaboration with the Saudi Association for Liver Diseases and Transplantation. EILF have selected esteemed faculty; Prof. Massimo Colombo, Prof. Xavier Forns, Prof. Sven Franque and Prof. George Papatheodoridis to provide state of the art updates and education on HBV, HCV, HCC, and NASH to local physicians at this interactive event.

Tags:

Categorised in:

This post was written by SOTO Admin

Event Alert: Workshop on viral Hepatitis elimination among people who inject drugs (PWID) in Italy on 10 October 2018

June 14, 2018 2:58 pm Published by Leave your thoughts1 Comment% Comments

In conjunction with San Patrignano, one of Europe’s largest drug rehabilitation centres, EILF will be holding a one-day workshop entitled “Viral Hepatitis Elimination in PWID: A Roadmap for Elimination in Italy” on 10 October 2018 in Rimini, Italy. This workshop will bring together leading experts in viral hepatitis, the drug treatment community in Italy and key stakeholders such as government officials, industry representatives, patient organisations and scientific societies. The workshop aims to not only kick start the call to action for viral hepatitis in PWID in Italy but also to generate a multi-stakeholder plan of action to turn this vision into a reality.

 

 

Tags:

Categorised in:

This post was written by SOTO Admin